Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PUTATIVE PRENEOPLASTIC LESIONS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 67 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Uchida, K; Kado, S; Ando, M; Nagata, Y; Takagi, A; Onoue, M
      A mucinous histochemical study on malignancy of aberrant crypt foci (ACF) in rat colon

      JOURNAL OF VETERINARY MEDICAL SCIENCE
    2. Tsukamoto, T; Fukami, H; Yamanaka, S; Yamaguchi, A; Nakanishi, H; Sakai, H; Aoki, I; Tatematsu, M
      Hexosaminidase-altered aberrant crypts, carrying decreased hexosaminidase alpha and beta subunit mRNAs, in colon of 1,2-dimethylhydrazine-treated rats

      JAPANESE JOURNAL OF CANCER RESEARCH
    3. Gokmen-Polar, Y; Murray, NR; Velasco, MA; Gatalica, Z; Fields, AP
      Elevated protein kinase C beta II is an early promotive event in colon carcinogenesis

      CANCER RESEARCH
    4. Roncucci, L; Pedroni, M; Vaccina, F; Benatti, P; Marzona, L; De Pol, A
      Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics

      CELL PROLIFERATION
    5. Bolt, AB; Papanikolaou, A; Delker, DA; Wang, QS; Rosenberg, DW
      Azoxymethane induces Ki-ras activation in the tumor resistant AKR/J mouse colon

      MOLECULAR CARCINOGENESIS
    6. Magnuson, BA; South, EH; Exon, JH; Dashwood, RH; Xu, M; Hendrix, K; Hubele, S
      Increased susceptibility of adult rats to azoxymethane-induced aberrant crypt foci

      CANCER LETTERS
    7. Li, W; Wanibuchi, H; Salim, EI; Wei, M; Yamamoto, S; Nishino, H; Fukushima, S
      Inhibition by ginseng of 1,2-dimethylhydrazine induction of aberrant cryptfoci in the rat colon

      NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
    8. Nakae, D
      Endogenous liver carcinogenesis in the rat

      PATHOLOGY INTERNATIONAL
    9. Tsukamoto, T; Kozaki, K; Nishikawa, Y; Yamamota, M; Fukami, H; Inoue, M; Wakabayashi, K; Tatematsu, M
      Development and distribution of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced aberrant crypt foci in the rat large intestine

      JAPANESE JOURNAL OF CANCER RESEARCH
    10. Bognel, C; Grandjouan, S
      Colonic flat adenomas and other dysplastic flat polyps.

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    11. Ioachim, HL
      Morphology of human carcinogenesis

      ANTICANCER RESEARCH
    12. Fenoglio-Preiser, CM; Noffsinger, A
      Aberrant crypt foci: A review

      TOXICOLOGIC PATHOLOGY
    13. Kristt, D; Bryan, K; Gal, R
      Colonic aberrant crypts may originate from impaired fissioning: Relevance to increased risk of neoplasia

      HUMAN PATHOLOGY
    14. Murray, NR; Davidson, LA; Chapkin, RS; Gustafson, WC; Schattenberg, DG; Fields, AP
      Overexpression of protein kinase C beta(II) induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis

      JOURNAL OF CELL BIOLOGY
    15. Ghirardi, M; Nascimbeni, R; Villanacci, V; Fontana, MG; Di Betta, E; Salerni, B
      Azoxymethane-induced aberrant crypt foci and colorectal tumors in F344 rats: Sequential analysis of growth

      EUROPEAN SURGICAL RESEARCH
    16. Loft, S; Deng, XS; Tuo, JS; Wellejus, A; Sorensen, M; Poulsen, HE
      Experimental study of oxidative DNA damage

      FREE RADICAL RESEARCH
    17. Nakae, D; Denda, A; Kobayashi, Y; Akai, H; Kishida, H; Tsujiuchi, T; Konishi, Y; Suzuki, T; Muramatsu, M
      Inhibition of early-phase exogenous and endogenous liver carcinogenesis intransgenic rats harboring a rat glutathione S-transferase placental form gene

      JAPANESE JOURNAL OF CANCER RESEARCH
    18. PAULSEN JE; STAMM T; ALEXANDER J
      A FISH OIL-DERIVED CONCENTRATE ENRICHED IN EICOSAPENTAENOIC AND DOCOSAHEXAENOIC ACID AS ETHYL-ESTERS INHIBITS THE FORMATION AND GROWTH OF ABERRANT CRYPT FOCI IN RAT COLON

      Pharmacology & toxicology
    19. DAVIES MJ; RUMSBY PC
      LONG-TERM ANALYSIS OF COLONIC ABERRANT CRYPT FORMATION AFTER TREATMENT OF SPRAGUE-DAWLEY RATS WITH AZOXYMETHANE

      Teratogenesis, carcinogenesis, and mutagenesis
    20. KENNEDY AR
      CHEMOPREVENTIVE AGENTS - PROTEASE INHIBITORS

      Pharmacology & therapeutics
    21. CORPET DE; PEIFFER G; TACHE S
      GLYCEMIC INDEX, NUTRIENT DENSITY, AND PROMOTION OF ABERRANT CRYPT FOCI IN RAT COLON

      Nutrition and cancer
    22. RAO CV; NEWMARK HL; REDDY BS
      CHEMOPREVENTIVE EFFECT OF SQUALENE ON COLON-CANCER

      Carcinogenesis
    23. SHPITZ B; BOMSTEIN Y; MEKORI Y; COHEN R; KAUFMAN Z; NEUFELD D; GALKIN M; BERNHEIM J
      ABERRANT CRYPT FOCI IN HUMAN COLONS - DISTRIBUTION AND HISTOMORPHOLOGIC CHARACTERISTICS

      Human pathology
    24. TAKAYAMA T; KATSUKI S; TAKAHASHI Y; OHI M; NOJIRI S; SAKAMAKI S; KATO J; KOGAWA K; MIYAKE H; NIITSU Y
      ABERRANT CRYPT FOCI OF THE COLON AS PRECURSORS OF ADENOMA AND CANCER

      The New England journal of medicine
    25. DOLARA P; CADERNI G; LANCIONI L; GIANNINI A; ANASTASI A; FAZI M; CASTIGLIONE G
      ABERRANT CRYPT FOCI IN HUMAN COLON CARCINOGENESIS

      Cancer detection and prevention
    26. DIGREGORI C; LOSI L; FANTE R; MODICA S; GHIDONI M; PEDRONI M; TAMASSIA MG; GAFA L; DELEON MP; RONCUCCI L
      HISTOLOGY OF ABERRANT CRYPT FOCI IN THE HUMAN COLON

      Histopathology
    27. CORPET DE; JACQUINET C; PEIFFER G; TACHE S
      INSULIN INJECTIONS PROMOTE THE GROWTH OF ABERRANT CRYPT FOCI IN THE COLON OF RATS

      Nutrition and cancer
    28. TAO LH; LI KW; PEREIRA MA
      CHEMOPREVENTIVE AGENTS-INDUCED REGRESSION OF AZOXYMETHANE-INDUCED ABERRANT CRYPT FOCI WITH THE RECOVERY OF HEXOSAMINIDASE ACTIVITY

      Carcinogenesis
    29. NUCCI MR; ROBINSON CR; LONGO P; CAMPBELL P; HAMILTON SR
      PHENOTYPIC AND GENOTYPIC CHARACTERISTICS OF ABERRANT CRYPT FOCI IN HUMAN COLORECTAL MUCOSA

      Human pathology
    30. YOKOTA T; SUGANO K; KONDO H; SAITO D; SUGIHARA K; FUKAYAMA N; OHKURA H; OCHIAI A; YOSHIDA S
      DETECTION OF ABERRANT CRYPT FOCI BY MAGNIFYING COLONOSCOPY

      Gastrointestinal endoscopy
    31. NAKAE D; KOBAYASHI Y; AKAI H; ANDOH N; SATOH H; OHASHI K; TSUTSUMI M; KONISHI Y
      INVOLVEMENT OF 8-HYDROXYGUANINE FORMATION IN THE INITIATION OF RAT-LIVER CARCINOGENESIS BY LOW-DOSE LEVELS OF N-NITROSODIETHYLAMINE

      Cancer research
    32. SIU IM; PRETLOW TG; AMINI SB; PRETLOW TP
      IDENTIFICATION OF DYSPLASIA IN HUMAN COLONIC ABERRANT CRYPT FOCI

      The American journal of pathology
    33. FUJIMITSU Y; NAKANISHI H; INADA K; YAMACHIKA T; ICHINOSE M; FUKAMI H; TATEMATSU M
      DEVELOPMENT OF ABERRANT CRYPT FOCI INVOLVES A FISSION MECHANISM AS REVEALED BY ISOLATION OF ABERRANT CRYPTS

      Japanese journal of cancer research
    34. TSUEI BJ; POVOSKI SP; ZHOU WG; BELL RH
      AUTORADIOGRAPHIC LOCALIZATION OF CHOLECYSTOKININ (CCK) RECEPTOR EXPRESSION DURING THE DEVELOPMENT OF AZASERINE-INDUCED RAT PANCREATIC-CARCINOMA

      Pancreas
    35. GHIA M; MATTIOLI F; MERETO E
      A POSSIBLE MEDIUM-TERM ASSAY FOR DETECTING THE EFFECTS OF LIVER AND COLON CARCINOGENS IN RATS

      Cancer letters
    36. WHITELEY LO; HUDSON L; PRETLOW TP
      ABERRANT CRYPT FOCI IN THE COLONIC MUCOSA OF RATS TREATED WITH A GENOTOXIC AND NONGENOTOXIC COLON CARCINOGEN

      Toxicologic pathology
    37. YAO KQ; LATTA M; BIRD RP
      MODULATION OF COLONIC ABERRANT CRYPT FOCI AND PROLIFERATIVE INDEXES IN COLON AND PROSTATE-GLANDS OF RATS BY VITAMIN-E

      Nutrition and cancer
    38. SHIRTLIFF N; BIRD RP
      GROWTH FEATURES OF ABERRANT CRYPT FOCI THAT RESIST MODULATION BY CHOLIC-ACID

      Carcinogenesis
    39. RICHMOND RE; CARTER JH; CARTER HW; DANIEL FB; DEANGELO AB
      HEPATOCYTE EXPRESSION OF TUMOR-ASSOCIATED ALDEHYDE DEHYDROGENASE (ALDH-3) AND P21 RAS FOLLOWING DIETHYLNITROSAMINE (DEN) INITIATION AND CHRONIC EXPOSURE TO DI(2-ETHYLHEXYL)PHTHALATE (DHEP)

      Carcinogenesis
    40. PEREIRA MA; BARNES LH; STEELE VE; KELLOFF GV; LUBET RA
      PIROXICAM-INDUCED REGRESSION OF AZOXYMETHANE-INDUCED ABERRANT CRYPT FOCI AND PREVENTION OF COLON-CANCER IN RATS

      Carcinogenesis
    41. FERGUSON LR; HARRIS PJ
      STUDIES ON THE ROLE OF SPECIFIC DIETARY-FIBERS IN PROTECTION AGAINST COLORECTAL-CANCER

      Mutation research
    42. BJERKNES M
      EXPANSION OF MUTANT STEM-CELL POPULATIONS IN THE HUMAN COLON

      Journal of theoretical biology
    43. LOSI L; RONCUCCI L; DIGREGORIO C; DELEON MP; BENHATTAR J
      K-RAS AND P53 MUTATIONS IN HUMAN COLORECTAL ABERRANT CRYPT FOCI

      Journal of pathology
    44. FENG Y; WAGNER RJ; FRETLAND AJ; BECKER WK; COOLEY AM; PRETLOW TP; LEE KJ; HEIN DW
      ACETYLATOR GENOTYPE (NAT2)-DEPENDENT FORMATION OF ABERRANT CRYPTS IN CONGENIC SYRIAN-HAMSTERS ADMINISTERED 3,2'-DIMETHYL-4-AMINOBIPHENYL

      Cancer research
    45. BRIERE KM; KUESEL AC; BIRD RP; SMITH ICP
      H-1 MR VISIBLE LIPIDS IN COLON TISSUE FROM NORMAL AND CARCINOGEN-TREATED RATS

      NMR in biomedicine
    46. BALDWIN GS
      THE ROLE OF GASTRIN AND CHOLECYSTOKININ IN NORMAL AND NEOPLASTIC GASTROINTESTINAL GROWTH

      Journal of gastroenterology and hepatology
    47. PRETLOW TG; NAGABHUSHAN M; PRETLOW TP
      PROSTATIC INTRAEPITHELIAL NEOPLASIA AND OTHER CHANGES DURING PROMOTION AND PROGRESSION

      Pathology research and practice
    48. BIRD RP
      ROLE OF ABERRANT CRYPT FOCI IN UNDERSTANDING THE PATHOGENESIS OF COLON-CANCER

      Cancer letters
    49. ROSENBERG DW; LIU Y
      INDUCTION OF ABERRANT CRYPTS IN MURINE COLON WITH VARYING SENSITIVITYTO COLON CARCINOGENESIS

      Cancer letters
    50. BIRD RP
      FURTHER INVESTIGATION OF THE EFFECT OF CHOLIC-ACID ON THE INDUCTION, GROWTH-CHARACTERISTICS AND STABILITY OF ABERRANT CRYPT FOCI IN RAT COLON

      Cancer letters
    51. HERRINGTON MK; ADRIAN TE
      ON THE ROLE OF CHOLECYSTOKININ IN PANCREATIC-CANCER

      International journal of pancreatology
    52. KRISTIANSEN E; THORUP I; MEYER O
      INFLUENCE OF DIFFERENT DIETS ON DEVELOPMENT OF DMH-INDUCED ABERRANT CRYPT FOCI AND COLON-TUMOR INCIDENCE IN WISTAR RATS

      Nutrition and cancer
    53. PRETLOW TP
      ABERRANT CRYPT FOCI AND K-RAS MUTATIONS - EARLIEST RECOGNIZED PLAYERSOR INNOCENT BYSTANDERS IN COLON CARCINOGENESIS

      Gastroenterology
    54. OTORI K; SUGIYAMA K; HASEBE T; FUKUSHIMA S; ESUMI H
      EMERGENCE OF ADENOMATOUS ABERRANT CRYPT FOCI (ACF) FROM HYPERPLASTIC ACF WITH CONCOMITANT INCREASE IN CELL-PROLIFERATION

      Cancer research
    55. CADERNI G; GIANNINI A; LANCIONI L; LUCERI C; BIGGERI A; DOLARA P
      CHARACTERIZATION OF ABERRANT CRYPT FOCI IN CARCINOGEN-TREATED RATS - ASSOCIATION WITH INTESTINAL CARCINOGENESIS

      British Journal of Cancer
    56. POVOSKI SP; ZHOU WG; LONGNECKER DS; BELL RH
      CHOLECYSTOKININ RECEPTOR CHARACTERIZATION AND CHOLECYSTOKININ-A RECEPTOR MESSENGER-RNA EXPRESSION IN TRANSGENIC MOUSE PANCREATIC CARCINOMASAND DYSPLASTIC PANCREAS

      Oncology research
    57. YAMASHITA N; MINAMOTO T; ONDA M; ESUMI H
      INCREASED CELL-PROLIFERATION OF AZOXYMETHANE-INDUCED ABERRANT CRYPT FOCI OF RAT COLON

      Japanese journal of cancer research
    58. MERETO E; FRENCIA L; GHIA M
      EFFECT OF ASPIRIN ON INCIDENCE AND GROWTH OF ABERRANT CRYPT FOCI INDUCED IN THE RAT COLON BY 1,2-DIMETHYLHYDRAZINE

      Cancer letters
    59. THORUP I; MEYER O; KRISTIANSEN E
      INFLUENCE OF A DIETARY FIBER ON DEVELOPMENT OF DIMETHYLHYDRAZINE-INDUCED ABERRANT CRYPT FOCI AND COLON-TUMOR INCIDENCE IN WISTAR RATS

      Nutrition and cancer
    60. MAGNUSON BA; SHIRTLIFF N; BIRD RP
      RESISTANCE OF ABERRANT CRYPT FOCI TO APOPTOSIS INDUCED BY AZOXYMETHANE IN RATS CHRONICALLY FED CHOLIC-ACID

      Carcinogenesis
    61. QIN XS; ZARKOVIC M; NAKATSURU Y; ARAI M; ODA H; ISHIKAWA T
      DNA ADDUCT FORMATION AND ASSESSMENT OF ABERRANT CRYPT FOCI IN-VIVO INTHE RAT COLON MUCOSA AFTER TREATMENT WITH N-METHYL-N-NITROSOUREA

      Carcinogenesis
    62. PEREIRA MA; BARNES LH; RASSMAN VL; KELLOFF GV; STEELE VE
      USE OF AZOXYMETHANE-INDUCED FOCI OF ABERRANT CRYPTS IN RAT COLON TO IDENTIFY POTENTIAL CANCER CHEMOPREVENTIVE AGENTS

      Carcinogenesis
    63. SHIVAPURKAR N; TANG ZC; FERREIRA A; NASIM S; GARETT C; ALABASTER O
      SEQUENTIAL-ANALYSIS OF K-RAS MUTATIONS IN ABERRANT CRYPT FOCI AND COLONIC TUMORS INDUCED BY AZOXYMETHANE IN FISCHER-344 RATS ON HIGH-RISK DIET

      Carcinogenesis
    64. LAFAVE LMZ; KUMARATHASAN P; BIRD RP
      EFFECT OF DIETARY-FAT ON COLONIC PROTEIN-KINASE-C AND INDUCTION OF ABERRANT CRYPT FOCI

      Lipids
    65. PRETLOW TP; ROUKHADZE EV; ORIORDAN MA; CHAN JC; AMINI SB; STELLATO TA
      CARCINOEMBRYONIC ANTIGEN IN HUMAN COLONIC ABERRANT CRYPT FOCI

      Gastroenterology
    66. CARTER JW; LANCASTER HK; HARDMAN WE; CAMERON IL
      DISTRIBUTION OF INTESTINE-ASSOCIATED LYMPHOID-TISSUE, ABERRANT CRYPT FOCI, AND TUMORS IN THE LARGE-BOWEL OF 1,2-DIMETHYLHYDRAZINE-TREATED MICE

      Cancer research
    67. MAGNUSON BA; CARR I; BIRD RP
      ABILITY OF ABERRANT CRYPT FOCI CHARACTERISTICS TO PREDICT COLONIC TUMOR-INCIDENCE IN RATS FED CHOLIC-ACID

      Cancer research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/11/20 alle ore 01:21:48